An open label, multicenter clinical trial that investigated the efficacy and safety of leuprorelin treatment of central precocious puberty in Chinese children

BACKGROUND: Leuprorelin is an analog of gonadotropin-releasing hormone that is used for the therapy of central precocious puberty (CPP). The aims of this prospective, open label, multicenter clinical trial were to establish its efficacy and safety during long-term use. METHODS: Patients, who were al...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xiaoping, Hou, Ling, Zhong, Yan, You, Cheng, Yang, Yu, Wu, Xian, Li, Pin, Zhou, Shasha, Qiu, Wenjuan, Zhang, Huiwen, Liu, Ying, Qian, Ye, Luo, Feihong, Cheng, Ruoqian, Hu, Yuhua, Gong, Haihong, Wang, Qing, Xu, Zhuangjian, Du, Hongwei, Lu, Feiyu, Fu, Junfen, Chen, Xuefeng, Wang, Winston, Guo, Ziheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
6200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702188/
https://www.ncbi.nlm.nih.gov/pubmed/34941067
http://dx.doi.org/10.1097/MD.0000000000028158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702188/
https://www.ncbi.nlm.nih.gov/pubmed/34941067
http://dx.doi.org/10.1097/MD.0000000000028158

Ejemplares similares